Sanofi rabies vax shortage eases; Japan reports malaria success;

> The CDC has lifted supply restrictions on Sanofi's ($SNY) rabies vaccine after a shortage eased. News

> Japanese vaccine researchers have reported success in cutting the risk of malaria. Piece

> Health workers are reportedly considering using an injectable polio vaccine in Pakistan. Item

> More than two-thirds of medical vaccine posts on Twitter are backed by scientific research. Study

> The death of a child has sparked a surge in demand for a vaccine against bat bites. Article

> Islamic extremists are persuading some Somali parents to turn down polio vaccines. News

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.